These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38738281)

  • 1. A retrospective study comparing the results of continuous glucose monitoring to self-blood glucose monitoring for pregnant women with type 1 diabetes mellitus.
    Khan AA; Ata F; Alsharkawy NAAS; Othman EMM; Hassan IM; Taha FAM; Baagar K; Ali H; Konje JC; Abou-Samra AB; Bashir M
    Expert Rev Endocrinol Metab; 2024 May; ():1-7. PubMed ID: 38738281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in diabetes management: have pregnancy outcomes in women with type 1 diabetes changed in the last decades?
    Citro F; Bianchi C; Nicolì F; Aragona M; Marchetti P; Di Cianni G; Bertolotto A
    Diabetes Res Clin Pract; 2023 Nov; 205():110979. PubMed ID: 37890701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus.
    Lason I; Cyganek K; Witek P; Matejko B; Malecki MT; Skupien J
    Ginekol Pol; 2021; 92(10):675-681. PubMed ID: 33914316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland.
    Cypryk K; Wender-Ozegowska E; Cyganek K; Sieradzki J; Skoczylas K; Chen X; Cordero TL; Shin J; Cohen O
    Acta Diabetol; 2023 Apr; 60(4):553-561. PubMed ID: 36653533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
    Feig DS; Donovan LE; Corcoy R; Murphy KE; Amiel SA; Hunt KF; Asztalos E; Barrett JFR; Sanchez JJ; de Leiva A; Hod M; Jovanovic L; Keely E; McManus R; Hutton EK; Meek CL; Stewart ZA; Wysocki T; O'Brien R; Ruedy K; Kollman C; Tomlinson G; Murphy HR;
    Lancet; 2017 Nov; 390(10110):2347-2359. PubMed ID: 28923465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Moy FM; Ray A; Buckley BS; West HM
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009613. PubMed ID: 28602020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol.
    Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR;
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
    Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
    Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous glucose monitoring results in lower HbA
    Paramasivam SS; Chinna K; Singh AKK; Ratnasingam J; Ibrahim L; Lim LL; Tan ATB; Chan SP; Tan PC; Omar SZ; Bilous RW; Vethakkan SR
    Diabet Med; 2018 Aug; 35(8):1118-1129. PubMed ID: 29663517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose variability as the risk factor of preeclampsia in pregnant patients with type 1 diabetes mellitus.
    Tiselko AV; Kapustin RV; Milyutina YP; Borovik NV; Abashova EI; Yarmolinskaya MI
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9639-9646. PubMed ID: 35264056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Jones LV; Ray A; Moy FM; Buckley BS
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009613. PubMed ID: 31120549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous glucose monitor use with and without remote monitoring in pregnant women with type 1 diabetes: A pilot study.
    Polsky S; Garcetti R; Pyle L; Joshee P; Demmitt JK; Snell-Bergeon JK
    PLoS One; 2020; 15(4):e0230476. PubMed ID: 32298269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic variability and indices of glycemic control among pregnant women with type 1 diabetes (T1D) based on the use of continuous glucose monitoring share technology.
    Sklar J; Pyle L; Snell-Bergeon JK; Garcetti R; Joshee P; Demmitt JK; Polsky S
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8968-8974. PubMed ID: 34875947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous glucose monitoring systems for type 1 diabetes mellitus.
    Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes.
    Poolsup N; Suksomboon N; Kyaw AM
    Diabetol Metab Syndr; 2013; 5():39. PubMed ID: 23876067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial.
    Secher AL; Ringholm L; Andersen HU; Damm P; Mathiesen ER
    Diabetes Care; 2013 Jul; 36(7):1877-83. PubMed ID: 23349548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.